Kiniksa Pharmaceuticals, GmbH
Pharmaceuticals · Zug, Zug
Kiniksa Pharmaceuticals, GmbH is a Swiss pharmaceuticals company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2020 (UID CHE-404.899.773).
Board members & signatories
- Douglas Barry — Geschäftsführer
- Daniel Palmqvist — Geschäftsführer
- Martina Struck-Donatz — Geschäftsführer
Registered purpose
Erforschung, Entwicklung und Vermarktung von therapeutischen Gesundheitsprodukten zur Behandlung von Menschen, einschliesslich, jedoch nicht beschränkt auf Herstellung, Durchführung klinischer Studien, Einreichung von Zulassungen und Interaktion mit Regierungs- und Aufsichtsbehörden, Aktivitäten in medizinischen Angelegenheiten, einschliesslich Aufklärung über Krankheiten, Vermarktung, Förderung u…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Kiniksa Pharmaceuticals, does
OFFERING
Kiniksa Pharmaceuticals develops and commercializes biopharmaceutical products, focusing on immune modulation therapies. Their pipeline includes KPL-387, an investigational monoclonal antibody for recurrent pericarditis, and ARCALYST® (rilonacept), an FDA-approved therapy. The company is advancing multiple clinical-stage assets targeting significant unmet medical needs in various therapeutic areas.
Unlock the full analysis →Similar companies
- Rocket Pharmaceuticals GmbH — Pharmaceuticals · Zug
- Skyhawk Therapeutics Europe GmbH — Pharmaceuticals · Basel
- Crinetics Pharmaceuticals Europe GmbH — Pharmaceuticals · Zug
- Quercis Pharma AG — Pharmaceuticals · Zug
- DRK Research Solutions AG — Life Sciences Services (CRO / Consulting) · Vandoeuvres
- RDP Pharma AG — Pharmaceuticals · Romanshorn
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime